Dual Antibiotic Zerbaxa Gets FDA Nod for Bacterial Pneumonia Dual Antibiotic Zerbaxa Gets FDA Nod for Bacterial Pneumonia
Zerbaxa (ceftolozane and tazobactam) for hospital- and ventilator-associated bacterial pneumonia was initially approved for complicated intra-abdominal and urinary tract infections.FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news
More News: Bacterial Pneumonia | Drugs & Pharmacology | Hospitals | Pneumonia | Urinary Tract Infections